CADTH has received notice of a pending submission from Meda for azelastine hydrochloride with fluticasone propionate (Dymista) for patients with seasonal allergic rhinitis and allergic rhino-conjunctivitis.

For information about the patient input process or for additional instructions, please see the patient onput page of the CADTH website.Note that only patient groups may submit input.

For more details, go to: http://www.cadth.ca/en/products/cdr/patient-group-input-form/391